Phase 2 study of the CDK4 inhibitor abemaciclib in dedifferentiated liposarcoma Meeting Abstract


Authors: Dickson, M. A.; Koff, A.; D'Angelo, S. P.; Gounder, M. M.; Keohan, M. L.; Kelly, C. M.; Chi, P.; Antonescu, C. R.; Landa, J.; Qin, L. X.; Crago, A. M.; Singer, S.; Tap, W. D.
Abstract Title: Phase 2 study of the CDK4 inhibitor abemaciclib in dedifferentiated liposarcoma
Meeting Title: 55th Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title: Journal of Clinical Oncology
Volume: 37
Issue: 15 Suppl.
Meeting Dates: 2019 May 31-Jun 4
Meeting Location: Chicago, IL
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2019-05-20
Start Page: 563s
Language: English
ACCESSION: WOS:000487345804101
PROVIDER: wos
DOI: 10.1200/JCO.2019.37.15_suppl.11004
Notes: Meeting Abstract: 11004 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Andrew C Koff
    110 Koff
  2. Cristina R Antonescu
    895 Antonescu
  3. Ping Chi
    172 Chi
  4. Jonathan Landa
    37 Landa
  5. Li-Xuan Qin
    190 Qin
  6. Mary Louise Keohan
    124 Keohan
  7. Mrinal M Gounder
    228 Gounder
  8. Sandra Pierina D'Angelo
    252 D'Angelo
  9. Aimee Marie Crago
    106 Crago
  10. Samuel Singer
    337 Singer
  11. Mark Andrew Dickson
    169 Dickson
  12. William Douglas Tap
    372 Tap
  13. Ciara Marie Kelly
    89 Kelly